Nicole Metzendorf
Researcher at Department of Pharmacy; Biopharmaceuticals; ProDDe
- E-mail:
- nicole.metzendorf@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA

Publications
Recent publications
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Download full text (pdf) of Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Part of Frontiers in Neuroscience, 2025
- DOI for Key considerations for ELISA-based quantification of diverse amyloid beta forms in murine brain homogenates
- Download full text (pdf) of Key considerations for ELISA-based quantification of diverse amyloid beta forms in murine brain homogenates
-
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Frontiers in Pharmacology, 2025
- DOI for Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Download full text (pdf) of Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
-
Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
Part of Drug Delivery and Translational Research, p. 3321-3337, 2025
- DOI for Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
- Download full text (pdf) of Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
All publications
Articles in journal
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Download full text (pdf) of Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Part of Frontiers in Neuroscience, 2025
- DOI for Key considerations for ELISA-based quantification of diverse amyloid beta forms in murine brain homogenates
- Download full text (pdf) of Key considerations for ELISA-based quantification of diverse amyloid beta forms in murine brain homogenates
-
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Frontiers in Pharmacology, 2025
- DOI for Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Download full text (pdf) of Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
-
Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
Part of Drug Delivery and Translational Research, p. 3321-3337, 2025
- DOI for Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
- Download full text (pdf) of Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies
-
Part of Neurotherapeutics, 2025
- DOI for Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
- Download full text (pdf) of Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
-
Paralemmin-1 controls the nanoarchitecture of the neuronal submembrane cytoskeleton
Part of Science Advances, 2025
- DOI for Paralemmin-1 controls the nanoarchitecture of the neuronal submembrane cytoskeleton
- Download full text (pdf) of Paralemmin-1 controls the nanoarchitecture of the neuronal submembrane cytoskeleton
-
Part of Scientific Reports, 2024
- DOI for A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Download full text (pdf) of A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
Part of Journal of Alzheimer's Disease, p. 1017-1037, 2024
- DOI for Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease
- Download full text (pdf) of Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease
-
Part of Molecular Pharmaceutics, p. 1564-1576, 2023
- DOI for Standardized Preclinical In Vitro Blood-Brain Barrier Mouse Assay Validates Endocytosis-Dependent Antibody Transcytosis Using Transferrin-Receptor-Mediated Pathways
- Download full text (pdf) of Standardized Preclinical In Vitro Blood-Brain Barrier Mouse Assay Validates Endocytosis-Dependent Antibody Transcytosis Using Transferrin-Receptor-Mediated Pathways
-
Part of Journal of Neurochemistry, p. 413-425, 2023
- DOI for A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses
- Download full text (pdf) of A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses
-
Part of Alzheimer's Research & Therapy, 2023
- DOI for Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
- Download full text (pdf) of Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
-
Part of Neurotherapeutics, p. 1588-1602, 2022
- DOI for A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
- Download full text (pdf) of A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
-
Part of Frontiers in Microbiology, 2022
- DOI for Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen Clostridioides difficile
- Download full text (pdf) of Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen Clostridioides difficile
-
Part of Scientific Reports, 2022
- DOI for Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
- Download full text (pdf) of Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
-
Part of Alzheimer's Research & Therapy, 2022
- DOI for Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
- Download full text (pdf) of Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
-
Part of Translational Neurodegeneration, 2021
- DOI for Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
- Download full text (pdf) of Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
-
Part of Theranostics, p. 789-804, 2021
- DOI for Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
- Download full text (pdf) of Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
-
Part of ACS Chemical Neuroscience, p. 2529-2541, 2021
- DOI for Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
- Download full text (pdf) of Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide